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by biomedical journals with increasing frequency. In order to maintain the utility of such publi-
cations and avoid misguidance it is important that these studies are conducted to a high stan-
dard. This article aims to provide guidance both for those researchers undertaking and
reporting such studies and for the readers of such articles. Details of a suggested method
for conducting a systematic review are given, including methods for literature searches, data
abstraction and data extraction followed by a brief overview of common methods used for
meta-analyses and the interpretation of the results of meta-analysis.
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Evidence synthesis via the publication of systematic
reviews, particularly when these contain meta-analytical
combination of data, is now an established part of the
repertoire of many scientific journals. The number of
systematic reviews and meta-analyses has grown steadily
over the last two decades (Fig. 1).1 Systematic reviews have
significant benefits over conventional reviews in that all
available data is presented, not just that chosen by the44 1162523252; fax: þ44
(M.J. Bown).
ty for Vascular Surgery. Publisheauthors. However to ensure that this is the case, authors of
systematic reviews must be sure to perform their review
with rigorous attention to detail and report their methods
to enable adequate scrutiny of their conclusions. In the
reporting of the results from this type of research there is
the potential for erroneous conclusions to be presented by
the author or, drawn by the reader. If incorrect conclusions
are used to guide clinical decision making this may lead to
ineffectual or harmful treatment being administered. It
should also be remembered that the results from any
systematic review or meta-analysis are only as good as the
source data upon which they are based. Without proper
caution when combining studies potentially erroneous
conclusions can be reached. This is a particular problem if
the quality of the contributing studies is not considered or
analysed.d by Elsevier Ltd. All rights reserved.
Figure 1 The numbers of publications each year from 1988
to 2008 with the words “systematic review” (grey bars) or
“meta-analysis” (black bars) in the title. Data retrieved from
ISI Web of Knowledge based on a search of MEDLINE (1950-
present).
670 M.J. Bown, A.J. SuttonThere is often confusion regarding the precise definition
of what is a systematic review and what is a meta-analysis.
Both use bibliographic methods to obtain as complete as
possible a dataset of individual studies that have examined
the same hypothesis or related hypotheses and then
combine the data in order to reach an overall interpreta-
tion of the combined data. However, a meta-analysis
involves the mathematical combination of the results from
the source data whilst a systematic review does not. The
processes of mathematical combination used for meta-
analyses have their own particular set of methods and
standards for reporting. It is the reporting of these methods
and results that usually makes up a large proportion of the
difference between a systematic review and a meta-
analysis.
The potential for misinterpretation of data is particu-
larly problematic in meta-analyses. Because of the nature
of the statistical techniques used in meta-analyses the
majority of readers will not be familiar with interpreting
the significance of the presented data and in particular, the
interpretation of the various quality control measures (such
as publication bias assessment and the results of sensitivity
analyses). Furthermore, there is evidence to support
caution in the assumption that all meta-analyses provide
better evidence than individual trials. In 2005 a meta-
analysis of peri-operative beta blockade suggested that
there was a mortality benefit for this treatment (albeit with
increased side-effect profile)2 and this evidence led to
recommendations for the prescription of peri-operative
beta-blockers in patients undergoing non-cardiac surgery3
(although only approximately 40% of the patients in this
study underwent vascular surgical procedures). However,
since the publication of this meta-analysis, the result of
a large randomised controlled trial with twice as many
participants as the combined meta-analysis has become
available4 and this suggests that peri-operative beta
blockade is actually harmful e a finding contradictory to
the result of the previous meta-analysis. Readers should
also be aware that there is a hierarchy of evidence in meta-
analyses. The outputs from two meta-analyses may appear
similar but their quality is based upon the contributing
studies. A meta-analysis of several randomised controlled
trials with identical methods is of far greater quality thanone combining many observational studies with variable
inclusion/exclusion criteria, time periods or treatment
types.
The aim of this article is twofold. Firstly, we wish to
provide guidance to those researchers who are considering
undertaking any form of evidence synthesis whether this is
a systematic review, meta-analysis of comparative studies or
a meta-analysis of observational studies. Secondly, this
article aims to de-complicate the interpretation of meta-
analytical results and the methods used to check the
strength of the associations seen, and to enable the occa-
sional reader to critically appraise the evidence presented in
systematic reviews for their own benefit. The PRISMA
(Preferred Reporting Items for Systematic Reviews and Meta-
Analyses) statement provides specific guidance on the
conduct of systematic reviews and meta-analyses (with
a focus on meta-analyses of randomised controlled trials)
and the MOOSE (Meta-analysis Of Observational Studies in
Epidemiology) statement is specifically designed for meta-
analyses of observational studies.5,6 The Cochrane Handbook
for Systematic Reviews of Interventions7 is an essential
resource for those conducting systematic reviews and meta-
analyses, as is the United Kingdom National Institute for
Health Research Centre for Reviews and Dissemination.8 It is
not the authors’ intention to reproduce the work performed
by these groups and the available guidelines contained
within these works should be used in conjunction with this
article by authors preparing their own systematic reviews
and meta-analyses. Whilst diagnostic research can be
assessed through meta-analysis this area is outside the scope
of this review, full details of how to perform this type of
study can be found elsewhere.9
Part 1: Performing and Reporting a Systematic
Review
Planning a systematic review
The choice of subject for any review should be based on
either clinical or scientific need for the review. The review
should answer specific questions that need to be carefully
defined at the outset of the exercise and clearly stated in
the opening stages of any report. A useful method for
defining the exact clinical question(s) to be answered is to
categorise and specify the patient group, the intervention,
the comparison and the measured outcome. Simply
trawling the literature and ‘seeing what comes out’ is
more likely to add un-necessary outcomes of little rele-
vance rather than clarify available evidence. The overall
value of any review can only be related to the source
information. Ideally, there should be a good body of
evidence relating to the subject, if there is not then
a review is unlikely to add significantly to the evidence in
that area. This can only realistically be determined by
performing a literature search. One of the reasons for the
recent increase in the number of systematic reviews pub-
lished (Fig. 1) may be that multiple reviews of the same
subject are often now performed, as can be seen for
carotid stenting.10e13 Whilst the updating of a previously
published systematic review is to be encouraged,12 this
should only be performed if a large enough body of new
Quality Control in Systematic Reviews 671evidence has emerged since the previous publication and
redundancy should be avoided.Literature searches and study selection
Good quality systematic reviews necessitate good quality
literature searches, and accurate reporting of these
searches. Searching of single databases will only identify
a maximum of one third of all relevant articles and
searching multiple databases still only identifies half of all
available articles.14 The main databases used are Medline,
Embase, and The Cochrane Library. Common portals/
servers used to access these databases are PubMed and
Ovid although many others exist. It is important to appre-
ciate that one portal may only search a subset of any
particular database and for the most comprehensive
searches multiple portals in addition to multiple databases
should be used. The services of a clinical librarian or
information specialist should be employed to enhance the
quality of the literature search.
The use of multiple searches using multiple search
terms, different combinations of search terms and search
term synonyms also improves the effectiveness of an
electronic literature search. Where a search term is spelled
differently in different countries these alternative spellings
of search terms should be included as separate searches.
Study selection and exclusion criteria will affect the liter-
ature base for a systematic review. These both need to be
clearly stated in any report. The criteria used for inclusion
will often determine whether a meta-analysis can be per-
formed or not. If inclusion criteria are too strictly defined
then there will not be enough data to allow meaningful
combination of results. Conversely, if inclusion criteria are
non-specific a large dataset of non-homogenous studies will
be obtained. Since meta-analyses perform better in
homogenous datasets this strategy may result in meaning-
less output. However, this second strategy does allow for
the selection of subsets of studies that do demonstrate
homogeneity and will ensure that all relevant/possible
information is obtained from the review.
Many authors will exclude articles from a systematic
review or meta-analysis based upon language of publication
on the basis of practicality (e.g. translational expenses) and
since the majority of biomedical literature is published in
English language journals this is thought to include the
majority of relevant articles. However this approach is
possibly misconceived. If Medline (1950 to date) is searched
for the keyword “vascular surgery” 6088 articles are iden-
tified. When non-English language articles are excluded
only 4228 articles remain (search performed 26th
September 2009 using OvidSP_UI02.02.00.156). There is
evidence that this practice may have significant effects on
the results of a systematic review and currently should not
be accepted as a routine practice, particularly when meta-
analysis of clinical trials is being performed.15 In one study
a meta-analysis restricted to English language literature
that resulted in a treatment non-recommendation was re-
analysed including the non-English language literature. This
significantly altered the results of the meta-analysis and
demonstrated a positive treatment effect.16 However,
some authors suggest that language bias in most meta-analyses may not be as important as first thought - although
there is an effect in a minority of studies.17 Because of the
uncertainty surrounding the true effect of language bias
the exclusion of studies based on language should be fully
justified, the excluded studies should be clearly cited and,
in the case of meta-analyses of randomised trials, this
practice should not be encouraged. Publication language
should be considered during the sensitivity analysis phase
of a meta-analysis. Other exclusion criteria need to simi-
larly be stated and carefully considered prior to their
adoption. In cases where authors are uncertain regarding
the justification of any potential exclusion criteria these
should be not be used but instead applied to the study at
the time of performing a sensitivity analysis (vide infra).
Careful analysis of the studies obtained from a literature
search has to be made to look for possible duplicate
publication of the same data. Often this is not due to overt
publication of the same data in different journals but, more
commonly, due to multiple publications over time from
a single centre with later publications including the data
from earlier publications. To screen for this it is often
useful to extract the location and institution where studies
were performed and the start and finish dates of the study.
Systematic reviews are performed at a single specific
point in time. By their nature they become outdated as
soon as new evidence in their subject area becomes avail-
able, which is often prior to the publication of the review
itself. The date at which the literature search was per-
formed needs to be reported precisely. This then enables
future researchers to update the systematic review by
simply repeating the search from that time point. This also
underlines the need for accurate reporting of the overall
search strategy. This ability to update systematic reviews is
central to the principles that underlie the Cochrane
collaboration.18,19 However it should also be noted that
there is a danger of updating systematic reviews until
a positive result is identified20 and therefore updating
should continue beyond this point (there is the chance that
with the addition of future data a result may become non-
significant).
Good examples of literature search reporting can be
found in the systematic reviews by Rerkasem et al., Culwell
et al. and Rebollo Aguirre et al.21e23Data abstraction and extraction
Data abstraction (the selection of data items to be
extracted from each contributing article) and data
extraction form an essential part of any systematic review.
Often the data abstraction will depend upon the aims of the
systematic review and often form part of the selection
criteria for study inclusion. For example, if a systematic
review sets out to examine the effect of one particular
therapeutic intervention upon a clinical outcome the data
abstraction will include the number of patients studied, the
number receiving the intervention and the clinical
outcomes in each group. There would be little point in
selecting articles for inclusion in the review if this data was
not available and these variables become part of the
essential dataset. If a meta-analysis is to be included in the
review the primary data must include a measure of the
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672 M.J. Bown, A.J. Suttondispersion of any outcome estimate to enable statistical
combination. The data necessary to conduct a meta-anal-
ysis varies according to the outcome measure being
compared. Examples for several common scenarios are
shown in Table 1.
The gold standard for data extraction is for multiple
individuals to independently perform the data extraction,
compare results and resolve any discrepancies by
consensus. This approach necessitates good data abstrac-
tion prior to extraction since repeating data extraction in
this scenario is especially time-consuming. It is acceptable
to perform double data extraction on a proportion of the
data, check the level of agreement and if this is high,
continuing from this point with single individual data
extraction. Alternative, less robust, strategies include
single researchers conducting data extraction at two
separate time points or (the weakest strategy) single
researchers conducting data extraction on a single
occasion.
Part 2: Process and Interpretation of Meta-
analyses
The first question it is necessary to answer when consid-
ering the incorporation of a meta-analysis into a systematic
review is whether there is enough individual study data to
warrant statistical combination. There is no fixed number
of studies or combined number of individuals that can be
used as a threshold to aid this decision. A small number of
studies with similar outcomes will provide a tidy statistical
result but one has to be sure that the amount of evidence
being combined is adequate to address the thesis posed.
The combination of larger numbers of studies (more than
20) permits more detailed analysis and more rigorous
quality control of the results obtained through sensitivity
analyses and publication bias assessments.
An important concept in all systematic reviews, in-
cluding meta-analyses is that of heterogeneity. This term is
often used in different circumstances at different times
during such studies. Heterogeneity refers to the amount of
variability seen between studies. Clinical heterogeneity can
arise from differences in the patient populations that were
examined in different studies or differences in treatments
used. Methodological heterogeneity is a result of differ-
ences in experimental design between studies. Statistical
heterogeneity is most frequently quoted since a measure
for this is derived as part of a meta-analysis and often used
to guide or modify the statistical analyses performed.
Whilst statistical heterogeneity is most commonly referred
to, it is probably more important to consider clinical and
methodological heterogeneity prior to performing any
meta-analytical statistical combination of results. The
reason behind this is that if it is considered that there is
a high level of clinical and/or methodological heteroge-
neity the decision to proceed with a meta-analysis has to be
reviewed.
Data types and outcome measures
Meta-analyses may be used to combine many different
types of outcome data. Dichotomous, categorical,
Quality Control in Systematic Reviews 673continuous, survival, event rate or a combination of data
types may be combined (pooled) using a variety of different
statistical methods. Many outcome measures are expressed
as ratios (odds, risk, hazard). These measures are centred
on a value of 1 which implies that there is no difference
between the treatment assessed and no intervention or, in
the case of observational studies, an even likelihood of the
event occurring by chance alone. It is important to note
that there is a difference between Odds Ratio (OR) and
Relative Risk (RR). Both are acceptable measures of effect
size. Odds Ratios are more useful for descriptive purposes
whilst for interventional treatment comparisons Relative
Risk is favoured.24
Meta-analytical models
Meta-analyses are usually conducted using either ‘fixed-
effects’ or ‘random-effects’ models (and this should be
stated by the authors). These models make different
assumptions about the overall outcome being assessed. For
fixed-effects meta-analyses it is assumed that there is
a fixed value for the outcome being measured in the whole
population and that each study contributing to the meta-
analysis is estimating this fixed value in its own sample
drawn from the total population. For random-effects meta-
analyses it is assumed that the outcome being estimated is
not of a fixed value in every population, but the values are
related between populations. Each study is therefore esti-
mating the value in its own study population and these
populations are randomly sampled from the overall pop-
ulation. The use of a fixed-effects model is indicated where
there is low heterogeneity (variability) in the individual
studies contributing to the meta-analysis, whilst random-
effects models are used when the contributing studies have
heterogeneous estimates of the outcome measure being
combined.
The decision to use a random-effects or fixed-effects
model is usually based on the degree of heterogeneity
between the individual studies. If the estimates of the
outcome of interest are approximately the same across all
studies the between-study-heterogeneity is said to be low
and it is therefore appropriate to use a fixed-effect model.
If the individual studies show a wide variation in theFigure 2 A forest plot of outcome data from a meta-analysis of 4 r
men aged 64 to 83. Note the logarithmic scale and the vertical line
case, screening) or control therapies. Reproduced with permission
aneurysm reduces overall mortality in men. A meta-analysis of the
aneurysms. European Journal of Vascular & Endovascular Surgery.outcome estimates (heterogeneity) then a random-effects
model is appropriate. Heterogeneity is usually assessed by
using a Cochran’s chi-squared test and P-values of less than
0.1 (and not the usual 0.05) indicate significant heteroge-
neity. This approach is limited however when the number of
studies is large as heterogeneity assessed by a simple chi-
squared test is often seen. This is largely because of the
high power to be able to detect even small degree of
heterogeneity with a large sample size (number of studies).
In this situation it may be that a chi-squared test may be
detecting heterogeneity that is not clinically meaningful
and this should be considered before dismissing a result due
to a high degree of heterogeneity. An alternative approach
is to use an H, R, tau2(t2) or I2 value.25 Unfortunately there
remains significant disagreement amongst the statistical
community regarding the interpretation and use of these
statistics.26e28 For the non-expert a Cochran’s Q P-value of
<0.1 or an I2 value greater than 50% should be considered
to represent significant between-study-heterogeneity and
a random-effects model should be used. It should also be
noted that if an author considers there to be clinical
heterogeneity between studies a random-effects model
should be used irrespective of the results of any statistical
test for heterogeneity.
Reporting of results
The reporting of results from meta-analyses should enable
the reader to examine the individual study data without
recourse to obtaining the references themselves. This should
include the numbers of patients, the types and numbers of
interventions and the outcomes in each experimental/
observed group. Detail should also be given of those criteria
that were used to determine sub-groups, selection for
sensitivity analyses or meta-regression analyses.
Graphical presentation of the results from meta-anal-
yses is routinely presented as forest plots (Fig. 2). These are
a combined tabular and graphical representation of each
individual study contributing to the meta-analysis. The
study identifier and outcome estimate for that study
together with a measure of outcome uncertainty (usually
a confidence interval) and the weight of that study in the
analysis are usually presented on the plot and a graphicalandomised trials of screening for Abdominal Aortic Aneurysm in
at the threshold between outcome favouring treatment (in this
from: Lindholt JS. Norman P. Screening for abdominal aortic
mid- and long-term effects of screening for abdominal aortic
36(2):167e71, 2008.
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Figure 3 a) A funnel plot demonstrating reasonable symmetry from a meta-analysis of 171 studies. b) A funnel plot demon-
strating marked asymmetry (77 studies). In this case the outcome measure was intra-operative mortality and the missing studies
that should occupy the lower right part of the funnel represent those with high intra-operative mortality rates. Both figures
reproduced with permission from Bown MJ, Sutton AJ, Bell PR, Sayers RD. A meta-analysis of 50 years of ruptured abdominal aortic
aneurysm repair. Br J Surg. 2002 Jun;89(6):714e30.
674 M.J. Bown, A.J. Suttonrepresentation with point size indicating the analysis
weighting and error bars indicating the confidence interval.
At the bottom of the plot the combined outcome estimate
and model statistics are given on the left and a diamond on
the graphical portion indicates the estimate, with its width
representing the confidence interval of the estimate. A
solid vertical line on the plot at an outcome measure
equivalent to no difference between treatments or no
difference from the outcome expected by chance is usually
present. Occasionally an interrupted vertical line is marked
from the centre of the combined outcome estimate. The
distribution of the studies and their confidence intervals
around the combined estimate can also provide visual clues
as to the overall degree of heterogeneity in the analysis and
which studies are responsible for this heterogeneity. Forestplots are often modified to include data from several
distinct meta-analyses or to present data from sub-groups
within meta-analyses.
Publication bias
The predisposition of journals to favour publication of
positive reports over negative investigative findings29 and
the reticence of authors to publish poor outcomes
(particularly in surgical specialities) leads to a high chance
that a meta-analysis may be affected by these publication
biases. It is therefore important to check for the presence
of publication bias in any dataset used to perform a meta-
analysis. Moreover, the assessment of potential publication
bias is deemed to be an essential part of performing
Quality Control in Systematic Reviews 675meta-analyses6 but despite this, it is often missing from
reports.30
The most commonly used method to assess a dataset for
potential publication bias is through the construction of
funnel plots.31 Funnel plots are scatter plots with one
point for each study included in the meta-analysis. The
outcome measure for each study is plotted on the x-axis
against a measure of study accuracy on the y-axis (usually
the same value used to weight that particular study in the
meta-analysis although study size can be used). The
highest weighted/largest/most accurate studies will align
to the overall outcome seen in the meta-analysis. With
decreasing size the individual study outcomes will deviate
more from the overall meta-analytical outcome. If there is
no publication bias present these smaller studies will be
distributed evenly each side of the overall meta-analytical
outcome and the plot will resemble an inverted funnel
(Fig. 3a). If the funnel is asymmetric (Fig. 3b) this implies
that there are studies ‘missing’ from the literature. This
analysis can be assisted through the use of contour-
enhanced funnel plots or statistical testing for asymme-
try.31,32 Depending on the position of the missing studies
inferences can be drawn as to whether they represent
studies with poor outcomes (as in Fig. 3b) or suppression of
positive results. The precise causes of publication bias
cannot be drawn from funnel plots but can include true
publication bias (journals only publishing positive results),
poor design in smaller studies, fraud and, in surgery,
technical zealots producing good personal results that do
not translate into the general population. It is important to
remember that publication bias is not the only cause of
funnel plot asymmetry.33,34 Care should be taken whenTable 2 Essential criteria to be included in systematic reviews
Systematic reviews
Definition of intervention/technique/subject of
systematic review
Literature search
Search terms and combinations
Databases used
Date of search
Hand searching of references used?
Authors performing literature search
(must be at least 2)
Inclusion and exclusion criteria explicitly defined
Data abstraction
Authors performing data extraction
Study flow diagram
All submissions must include a summary stating in 50 words or less wh
addressed.
a Additional requirements in addition to those required for systemaexamining funnel plots constructed from small numbers of
studies. For example in the study by Agarwal et al.35 the
funnel plot shows asymmetry in just 5 studies plotted but
if the smallest study is removed the plot resumes a more
symmetrical shape. Some authors construct funnel plots
with the axes reversed36 however this does not alter
the method for interpretation. If there is evidence of
publication bias it is possible to attempt corrections of the
meta-analysis to compensate for these missing studies.
Methods that have been used are ‘trim and fill’,37 regres-
sion based methods,38 and the exclusion the studies
judged to be contributing to the asymmetry by visual
assessment.39
Sensitivity and sub-group analyses
A sensitivity analysis is an important part of a meta-anal-
ysis as it aims to determine the robustness of the observed
outcomes to the assumptions made in performing the
analysis. Unfortunately this essential part of meta-analyses
is often either not performed or reported. There is no set
strategy for performing a sensitivity analysis. The under-
lying principle is to repeat the primary analysis with an
altered dataset or statistical method to determine whether
these changes have any effect on the combined outcome
estimate. When altering the dataset, the choice of studies
to add or remove is often based on assumptions of quality
or study size and is usually at the author’s discretion. It
may be that a meta-analysis contains a mixture of rando-
mised and non-randomised clinical trials or multi-centre
and single-centre studies. Studies perceived to be of lower
quality are removed and the analysis is then repeated. Ifand meta-analyses.
Meta-analysesa
Outcomes listed
Methods
Software package
Weighting method
Heterogeneity assessment
Choice of fixed or random-effects model
Characteristics of studies contributing to meta-analysis:
Study-level inclusion/exclusion criteria
Individual study methodology
Study participants
Timescale
Setting.
Results
Statement of main outcome
Forest plot(s)
Sensitivity analysis
Publication bias assessment
at that study has added to the current knowledge of the subject
tic reviews.
676 M.J. Bown, A.J. Suttonthe analysis is robust then there should be little change in
the overall outcome estimate. An alternative to removing
studies based on quality criteria is to include studies
excluded a priori during the data-abstraction phase of the
meta-analysis. Sensitivity analyses can be performed by
altering the statistical model (for example applying
a fixed-effects model in the sensitivity analysis where
a random-effects model has been used initially and vice
versa).
Meta-analyses combine data by definition and in this
process subtle effects or differences between individual
studies may be lost in an attempt to aggregate enough data
to permit analysis. Sub-group analyses attempt to pick out
this lost information and are similar to sensitivity analyses
in that the dataset is re-analysed except for the fact that
rather than adding/removing studies the entire dataset is
analysed but divided by some factor of interest to the
authors. The danger with sub-group analyses is that the
amount of primary data being put forward into each anal-
ysis is usually small and conclusions drawn from these
smaller datasets have to be guarded.
There are many examples in the literature of meta-
analyses where sensitivity analysis has not been performed.
Some examples where sensitivity analyses have been per-
formed can be found35,40 however the adoption of this
practice is by no means universal.
Meta-regression
In meta-analyses, as with many statistical analyses we wish
to determine how an independent factor may affect our
outcome measure. In conventional statistical techniques
regression is used to determine the effect of one factor upon
an outcome variable and a similar technique called meta-
regression can be employed as part of ameta-analysis. Meta-
regression is similar to sub-group analysis except the factors
chosen are usually continuous, such as the publication date
of each study contributing to the meta-analysis or the
median age of patients in each study contributing to the
meta-analysis. It should be noted that sub-group analysis
could be performed using meta-regression techniques. If
meta-regression is used for sub-group analysis formal
statistical tests to determine differences between sub-
groups are available.Meta-regression is particularly useful to
determine whether an outcome changes with respect to the
factor, for example time. It does suffer from the same limi-
tations as sub-group analysis and requires a large volume of
individual studies to make meaningful interpretations from
the data. It should also be remembered that P-values quoted
for the regression equation are based on the null hypothesis
that the slope of the regression line is zero and significant
outcomes simply suggest that there is a relationship between
the factor and outcome being compared. Meta-regression
usually assumes a linear relationship between the explana-
tory variable and the outcome measure.
Computer software
The conduct of meta-analysis is greatly facilitated by the
use of statistical packages with meta-analysis functionality
or stand-alone specialised applications.41 Freely availableuser macros for the commercial package Stata42 and the
freely available package R43 offer extensive functionality
but require some programming knowledge of the underlying
software platform. One of the most commonly used stand-
alone packages is the software developed by the Cochrane
Collaboration, Revman (freely available for academic use),
which has an intuitive graphical user interface.18 Other
non-freeware packages include Comprehensive meta-anal-
ysis,44 MIX 2.041,45 (although a less powerful freeware
version is available) and StatsDirect46 (the latter two
provide front-ends to EXCEL).
Conclusions and guidelines for authors
We have attempted to clarify the processes behind
evidence synthesis projects with particular reference to
literature searching for systematic reviews and the inter-
pretation of meta-analyses. The primary aim of this piece
of work is to aid readers in the critical review of such
articles but in doing so several quality criteria can be drawn
for which authors submitting such articles to biomedical
journals such as The European Journal of Vascular and
Endovascular Surgery should consider. These are listed in
Table 2. As stated above, these criteria should be used in
conjunction with the guidelines already published by the
international consensus committees5,6 and are not inten-
ded to replace them.
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